Derivatix Quarterly Report: 2021-Q2 as of Jun. 30th, 2021
2021-Q2 Market Summary*: U.S. equity benchmarks closed the first half of 2021 at or near record highs as the economy...
Derivatix Quarterly Report: 2021-Q1 as of Mar. 30th, 2021
2020-Q4 Market Summary*: Efficient U.S. vaccination distribution, $1.9 trillion in fiscal stimulus, and a proposed $2 trillion infrastructure bill are...
Derivatix Quarterly Report: Mid 2021-Q1 as of Feb. 16th 2021
2021-Q1 Market Summary*: U.S. equities reversed losses and staged a rally as Federal Reserve Chairman Jerome Powell reaffirmed his view...
Derivatix Quarterly Report: 2020-Q4 as of Dec. 31st, 2020
2020-Q4 Market Summary*: 2020 was a year of surprises. There was the speed at which the pandemic escalated, the severity...
Derivatix Quarterly Report: Mid 2020-Q4 as of Nov. 13th 2020
2020-Q4 Market Summary: The US election, as the major event of Q4, is now behind us. The market reacted positively...
Derivatix Quarterly Report: 2020-Q3 as of Sep. 30th 2020
After a devastating 1st quarter for the global, market, followed by a 2nd quarter recovery on the back of heavy...
Derivatix Quarterly Report: Mid 2020-Q3 as of Aug. 14th 2020
2020-Q3 Market Summary: The fastest 30% drawdown in the history of global equities in the first quarter followed by the...
Derivatix Quarterly Report: 2020-Q2 as of June 30th, 2020
During the Q1 of 2020, the market plunge came as the coronavirus pandemic ground the economy to a halt and...
Derivatix Quarterly Report: Mid 2020-Q2 as of May 15th, 2020
In line with some countries’ decision to re-open their economy in steady steps, the overall US market manages to make...
Derivatix Quarterly Report: 2020-Q1 as of Mar. 31st, 2020
It is finally the spring time ladies and gentlemen. However, we have to still enjoy it from the comfort of...
Recent Comments